Following a total revamp in its management, Cell BioSciences last week announced that it had placed its first next-generation protein analysis system at Stanford University School of Medicine in anticipation of its launch.

The new instrument, a CB1000 prototype, was placed in the laboratory of David Hirschberg, director of the Human Immune Monitoring Center at the university, who will use it to analyze oncoprotein activation. He will also help Cell BioSciences optimize the instrument.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.